Novoron Bioscience Awarded Christopher & Dana Reeve Foundation Grant

Continuing our successful start to 2026, we are pleased to announce that we have received a grant from the Christopher & Dana Reeve Foundation to support our work developing a novel therapeutic to improve the lives of people impacted by spinal cord injury (SCI). Securing this funding will enable in-depth investigation of the mechanisms by which NOVO-120 improves bladder function following SCI, advancing an area of high unmet need with direct and meaningful impact on patient quality of life. We thank the Foundation for their continued generous support of research in this critical area.

You can read more in the full press release: https://lnkd.in/gEF4-zih